Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

NCT02879643 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

ALL, Childhood
Lymphoblastic Leukemia, Acute, Childhood
Lymphoblastic Leukemia, Acute

Interventions

DRUG: Marqibo

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium

Collaborators

[object Object]